Prescient Therapeutics (ASX:PTX) 3-Year Book Growth Rate

: 4.60% (As of Dec. 2023)

View and export this data going back to 1986. Start your Free Trial

Prescient Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.03.

During the past 12 months, Prescient Therapeutics's average Book Value per Share Growth Rate was -17.60% per year. During the past 3 years, the average Book Value per Share Growth Rate was 4.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was -6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Prescient Therapeutics was 181.60% per year. The lowest was -74.10% per year. And the median was -18.60% per year.

Competitive Comparison

For the Biotechnology subindustry, Prescient Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prescient Therapeutics 3-Year Book Growth Rate Distribution

For the Biotechnology industry and Healthcare sector, Prescient Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Prescient Therapeutics's 3-Year Book Growth Rate falls into.

Prescient Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Prescient Therapeutics (ASX:PTX) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Prescient Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Prescient Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Prescient Therapeutics (ASX:PTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (ASX:PTX) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.ptxtherapeutics.com

Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

Prescient Therapeutics (ASX:PTX) Headlines

No Headlines